Lord, Abbett & Co
GDRX icon

Lord, Abbett & Co’s GoodRx Holdings GDRX Stock Holding History

Lord, Abbett & Co’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-365,000
Closed -$20.3M – 674
2020
Q3 		$20.3M Buy
+365,000
New +$19.3M 0.06% 379

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Lord, Abbett & Co's GDRX Position: Q4 2020 in Review

Lord, Abbett & Co sold out of GoodRx Holdings (GDRX) in Q4 2020, closing a stake of 365,000 shares — an estimated $20.3M sold.

Lord, Abbett & Co first reported a position in GDRX in Q3 2020 and held it in 1 quarter. The position peaked at $20.3M in Q3 2020. 192 funds tracked by Wall St. Rank hold GDRX as of Q4 2020.

  • Lord, Abbett & Co reported no remaining GoodRx Holdings position as of Q4 2020 after selling out during the quarter.
  • Lord, Abbett & Co sold 365,000 GoodRx Holdings shares in Q4 2020, an estimated $20.3M.
  • Lord, Abbett & Co first reported a position in GoodRx Holdings in Q3 2020 and held it in 1 quarter.
  • Lord, Abbett & Co's GoodRx Holdings position peaked at $20.3M in Q3 2020.
  • 192 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2020.

Based on Lord, Abbett & Co's 13F filing for Q4 2020, filed 9 Feb 2021.